期刊文献+

薏苡仁甘油三酯联合放化同步治疗无手术指征食管癌患者的临床研究 被引量:3

Clinical Study of Semen Coicis Triglycerides Combined with Synchronous Treatment of Radiotherapy and Chemotherapy for Esophagus Cancer Patients without Surgical Indications
下载PDF
导出
摘要 目的探讨薏苡仁甘油三酯联合放化同步治疗无手术指征食管癌患者的临床应用效果。方法选取无手术指征的食管癌患者70例,等分为两组,分别采用薏苡仁甘油三酯联合放化同步治疗(K组)及单纯放化疗联合方案(H组),比较两组疗效及不良反应情况。结果治疗4个疗程后,总有效率K组高于H组,但无统计学意义(P>0.05),Th-17频数比例、CD4+CD25+Tregs频数比例、IL-1、IL-6及TNF-ɑ含量H组均明显高于K组(P<0.05)。不良反应K组明显少于H组(P<0.05),不良反应严重程度K组与H组比较无统计学差异(P>0.05)。结论薏苡仁甘油三酯联合放化同步治疗无手术指征食管癌患者较单纯应用放化疗疗效更好,且能够较好地保护患者免疫功能,因而可以作为无法手术食管癌患者保守治疗的选择之一。 Objective To investigate the curative effect of semen coicis triglycerides combined with synchronous treatment of radiotherapy and chemotherapy for esophagus cancer patients without surgical indications. Methods 70 cases of esophagus cancer patients without surgical indications were randomly divided into 2 group,each with 35 cases. Group K received semen coicis triglycerides combined with synchronous treatment of radiotherapy and chemotherapy,and group H received synchronous treatment of radiotherapy and chemotherapy. The curative effects and adverse reactions of the 2 groups were compared. Results After 4 courses of treatment,the total effective rate of group K was higher than that of group H,but there had no statistical difference( P > 0. 05). The levels of Th-17 frequency,CD4 + CD25 + Tregs frequency,IL-1,IL-6 and TNF-ɑ of group H were significantly higher than those of group K( P < 0. 05). Adverse reactions of group K was significantly less than that of group H( P <0. 05),but the degree of adverse reactions between the 2 groups had no statistical difference( P > 0. 05). Conclusion Semen coicis triglycerides combined with synchronous treatment of radiotherapy and chemotherapy for esophagus cancer patients without the indications has better effects than synchronous treatment of radiotherapy and chemotherapy,and it can efficiently protect the patient’s immune function. It can be one of the conservative treatment options for esophageal cancer patients without surgical indications.
出处 《实用癌症杂志》 2015年第8期1139-1142,共4页 The Practical Journal of Cancer
基金 苏卫科基(p200947)
关键词 薏苡仁甘油三酯 放疗 化疗 食管癌 疗效 Semen coicis triglycerides Radiotherapy Chemotherapy Esophagus cancer Curative effect
  • 相关文献

参考文献16

二级参考文献50

  • 1曹新国,王礼文.人类免疫调控转录因子FOXP3研究进展[J].临床检验杂志,2006,24(1):63-65. 被引量:12
  • 2余永莉,李季蓉.康莱特逆转HL-60/ADR细胞耐药作用的研究[J].实用癌症杂志,2006,21(6):573-575. 被引量:5
  • 3李子庆,凌华海,廖春莲,蔡康荣,陈景胜.非小细胞肺癌患者化疗前后T淋巴细胞亚群变化的研究[J].肿瘤研究与临床,2007,19(2):118-119. 被引量:2
  • 4Ferrone S,Whiteside T L.Tumor microenvironment and immune escape[J].Surg Oneol Clin N Am.2007,16(4):755-774.
  • 5Meloni F,Morosini M,Solari N,et al.Foxp 3 expressing CD4+ CD25+ and CD8+ CD28-T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma[J].Human Immunol.2006,67(1-2):1-12.
  • 6Korn T,Bettelli E,Oukka M,et al.IL-17 and Th17 cells[J].AnnuRev Immunol,2009,27(1):485-517.
  • 7Dong C.Th17 cells in development:an updated view of their molecu-lar identity and genetic programming[J].Nat Rev Immunol,2008,8(5):337-348.
  • 8Kimura A,Naka T,Kishimoto T.IL-6 dependent and independentpathways in the development of interleukin 17-producing T helper cells[J].Proc Natl Acad Sci USA,2007,104(29):12099-12104.
  • 9Bettelli E,Korn T,Kuchroo VK.Th17:the third member of the ef-fector T cell trilogy[J].Curr Opin Immunol,2007,19(6):652-657.
  • 10Zhang JP,Yan J,Xu J,et al.Increased intratumoral IL-17-producingcells correlate with poor survival in hepatocellular carcinoma patients[J].J Hepatol,2009,50(5):980-989.

共引文献27

同被引文献69

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部